This department is offering a grant to explore novel imaging techniques for detecting persistent HIV and neuroimmune dysfunction in the central nervous system of individuals under ART therapy. The research aims to uncover mechanisms of neuroimmune dysfunction caused by HIV-1 and develop innovative approaches for identifying latent/reactivated HIV. Projects may involve high risk but offer potential for breakthrough discoveries. Domestic and international studies across basic, preclinical, and clinical research settings are welcome. Collaborative efforts and multidisciplinary teams are encouraged for proposals. Closing date for submissions is March 11, 2020.
Opportunity ID: 323088
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-MH-20-331 |
Funding Opportunity Title: | Novel Imaging Approaches for detection of Persistent HIV and Neuroimmune dysfunction associated with HIV In the Central Nervous System (CNS) (R21 Clinical Trial Not Allowed) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.242 — Mental Health Research Grants |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Dec 16, 2019 |
Last Updated Date: | Dec 16, 2019 |
Original Closing Date for Applications: | Mar 11, 2020 |
Current Closing Date for Applications: | Mar 11, 2020 |
Archive Date: | Apr 16, 2020 |
Estimated Total Program Funding: | – |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities City or township governments State governments Private institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Small businesses Others (see text field entitled “Additional Information on Eligibility” for clarification) Independent school districts Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Special district governments County governments |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | This Funding Opportunity Announcement (FOA) invites research applications to elucidate mechanisms of neuroimmune dysfunction caused by HIV-1 and to detect persistent/latent/reactivated HIV using novel imaging/neuroimaging approaches in the central nervous system in anti-retroviral therapy (ART) suppressed individuals. ?These studies may involve considerable risk but may lead to a breakthrough or to the development of novel techniques, agents, methods, measures, models, or strategies, or to the generation of pilot or feasibility data. Basic, preclinical and clinical research in domestic and international settings are of interest. Multidisciplinary research teams and collaborative alliances are encouraged but not required. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-MH-20-331.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
There are no related documents on this grant.
Packages
Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-E | Use for due dates on or before May 24, 2020 | PKG00257162 | Feb 11, 2020 | May 24, 2020 | View |
Package 1
Mandatory forms
323088 RR_SF424_2_0-2.0.pdf
323088 PHS398_CoverPageSupplement_4_0-4.0.pdf
323088 RR_OtherProjectInfo_1_4-1.4.pdf
323088 PerformanceSite_2_0-2.0.pdf
323088 RR_KeyPersonExpanded_2_0-2.0.pdf
323088 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
323088 RR_Budget_1_4-1.4.pdf
323088 RR_SubawardBudget30_1_4-1.4.pdf
323088 PHS398_ModularBudget_1_2-1.2.pdf
323088 PHS_AssignmentRequestForm_2_0-2.0.pdf